Gene therapy for Alzheimer's disease targeting CD33 reduces amyloid beta accumulation and neuroinflammation.
Griciuc A, Federico AN, Natasan J, Forte AM, McGinty D, Nguyen H, Volak A, LeRoy S, Gandhi S, Lerner EP, Hudry E, Tanzi RE, Maguire CA.
Griciuc A, et al. Among authors: forte am.
Hum Mol Genet. 2020 Oct 10;29(17):2920-2935. doi: 10.1093/hmg/ddaa179.
Hum Mol Genet. 2020.
PMID: 32803224
Free PMC article.